A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the ...

But new research presented at the European Heart Rhythm Association’s 2025 Congress shows that this widely used medication is ...

An experimental drug could be game-changing for millions of Americans with a higher genetic risk of cardiovascular disease.

Merck has signed a licensing deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion for its experimental heart ...

A recent study from the European Sudden Cardiac Arrest Network has found a possible connection between a widely used blood ...